Tema ETFs’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Other funds holding ITCI
PCM
HI
DKCM
UOC
FCM
Tema ETFs's ITCI Position: Q1 2025 in Review
Tema ETFs sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 3,388 shares — an estimated $283K sold.
Tema ETFs first reported a position in ITCI in Q4 2024 and held it in 1 quarter. The position peaked at $283K in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.
- Tema ETFs reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
- Tema ETFs sold 3,388 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $283K.
- Tema ETFs first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 1 quarter.
- Tema ETFs's Intra-Cellular Therapies Inc. position peaked at $283K in Q4 2024.
- 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.
Based on Tema ETFs's 13F filing for Q1 2025, filed 14 May 2025.